Gabapentin for Perioperative Pain Relief in Surgical Abortion

• Status: Completed
• Trial end date: 2018-03-30
• Target enrollment: 0
• Participant gender: Female

Summary

Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Nevada, Las Vegas
• Treatments: Gabapentin

Criteria

Inclusion Criteria:

• Women seeking surgical abortion between 5 and 23 6/7 weeks of ultrasound age.

• English or Spanish speaking

• eligible for office-based surgical pregnancy termination

Exclusion Criteria:

• present use of gabapentin or pregabalin,

• renal disease

• sensitivity or allergy to gabapentin

• Missed abortion